SNNLive caught up with Xiaochun "Chris" Xu, Ph.D., MBA, Chairman & CEO of ThermoGenesis Holdings, Inc. (NASDAQ: THMO), via Skype to discuss highlights for Q1 2020, ThermoGenesis and ImmuneCyte's Rapid COVID-19 Testing Kit and timetable for the test.
For more information about ThermoGenesis Holdings, Inc., please visit:
https://thermogenesis.com/The interview may contain forward looking statements about ThermoGenesis Holdings, Inc. ThermoGenesis Holdings, Inc.'s periodic filings with the Securities and Exchange Commission for more complete information.
About ThermoGenesis Holdings, Inc.
ThermoGenesis Holdings, Inc., formerly known as Cesca Therapeutics Inc., develops, commercializes and markets a range of automated technologies for CAR-T and other cell-based therapies. The Company currently markets a full suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology, including its semi-automated, functionally closed CAR-TXpress™ platform, which streamlines the manufacturing process for the emerging CAR-T immunotherapy market. For more information about ThermoGenesis, please visit: www.ThermoGenesis.com.
Subscribe NOW to SNN Network:
http://bit.ly/1Q5YfymNew videos are added almost every day to the SNN Network channel sharing fascinating stories and companies from the MicroCap stock market.
Get more SNN Network:
Website:
http://stocknewsnow.com/Follow Stock News Now:
https://twitter.com/StockNewsNowLike Stock News Now:
https://www.facebook.com/SnnInc/Follow Stock News Now on LinkedIn:
https://www.linkedin.com/company/stoc...Follow Stock News Now on StockTwits:
http://stocktwits.com/StockNewsNowSNN.Network is the Official YouTube Channel for the Small-, Micro- and Nano-cap markets by providing news, insights, education tools and expert commentary. Subscribe now to be notified when new CEO video interviews, WALL STREET VIEWS with investing experts and new episodes of the Planet MicroCap Podcast are LIVE!